Ellenbarrie Industrial Gases (ELLEN)₹288.65−3.74%Industrial Gases
At the end of the Jun 2026 quarter, Ellenbarrie Industrial Gases' shareholders were: promoters 77.17%, FIIs 1.09%, DIIs 11.60%, public 10.14%. Promoter holding is unchanged on the quarter. FII holding is down 0.90 percentage points from 1.99% a year earlier. 0.00% of promoter shares were pledged. It had 54,743 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Promoters | 77.18% | 77.18% | 77.18% | 77.17% | 77.17% |
| FIIs | 1.99% | 1.21% | 0.83% | 1.32% | 1.09% |
| DIIs | 10.54% | 14.34% | 15.39% | 12.99% | 11.60% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 10.29% | 7.27% | 6.60% | 8.52% | 10.14% |
| Promoter shares pledged | — | — | — | — | 0.00% |
| Number of shareholders | 2,08,149 | 55,934 | 53,009 | 52,784 | 54,743 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Padam Kumar Agarwala | Promoter | 48.89% | 0.00 |
| Varun Agarwal | Promoter | 19.52% | 0.00 |
| Shanti Prasad Agarwala | Promoter | 8.89% | 0.00 |
| Motilal Oswal Nifty Microcap 250 Index Fund | DII | 5.53% | −1.24 |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund | DII | 1.87% | 0.00 |
| Clarus Capital I | DII | 1.79% | +0.13 |
| Manisha Saraf | Promoter | 0.00% | 0.00 |
Promoters held 77.17% of Ellenbarrie Industrial Gases at the end of the Jun 2026 quarter, down 0.01 percentage points from 77.18% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 1.09% (down 0.23 percentage points from 1.32% a quarter earlier) and domestic institutions (DIIs) held 11.60% (down 1.39 percentage points from 12.99% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Ellenbarrie Industrial Gases had 54,743 shareholders at the end of the Jun 2026 quarter, against 2,08,149 a year earlier.
Motilal Oswal Nifty Microcap 250 Index Fund (DII) held 5.53% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.